Free Trial

Humana (HUM) Stock Price, News & Analysis

Humana logo
$238.58 -5.22 (-2.14%)
Closing price 07/3/2025 03:56 PM Eastern
Extended Trading
$238.58 0.00 (0.00%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Humana Stock (NYSE:HUM)

Key Stats

Today's Range
$238.07
$246.63
50-Day Range
$224.81
$263.08
52-Week Range
$212.45
$406.46
Volume
960,833 shs
Average Volume
1.81 million shs
Market Capitalization
$28.79 billion
P/E Ratio
16.87
Dividend Yield
1.48%
Price Target
$280.76
Consensus Rating
Hold

Company Overview

Humana Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

HUM MarketRank™: 

Humana scored higher than 93% of companies evaluated by MarketBeat, and ranked 77th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Humana has received a consensus rating of Hold. The company's average rating score is 2.30, and is based on 7 buy ratings, 16 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Humana has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Humana's stock forecast and price target.
  • Earnings Growth

    Earnings for Humana are expected to decrease by -20.28% in the coming year, from $16.47 to $13.13 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Humana is 16.87, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.65.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Humana is 16.87, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.64.

  • Price to Earnings Growth Ratio

    Humana has a PEG Ratio of 1.81. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Humana has a P/B Ratio of 1.75. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Humana's valuation and earnings.
  • Percentage of Shares Shorted

    3.53% of the float of Humana has been sold short.
  • Short Interest Ratio / Days to Cover

    Humana has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Humana has recently increased by 7.87%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Humana pays a meaningful dividend of 1.48%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Humana does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Humana is 25.04%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Humana will have a dividend payout ratio of 26.96% next year. This indicates that Humana will be able to sustain or increase its dividend.

  • Read more about Humana's dividend.
  • Percentage of Shares Shorted

    3.53% of the float of Humana has been sold short.
  • Short Interest Ratio / Days to Cover

    Humana has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Humana has recently increased by 7.87%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Humana has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 37 news articles for Humana this week, compared to 25 articles on an average week.
  • Search Interest

    Only 13 people have searched for HUM on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 9 people have added Humana to their MarketBeat watchlist in the last 30 days. This is a decrease of -31% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Humana insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.37% of the stock of Humana is held by insiders.

  • Percentage Held by Institutions

    92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Humana's insider trading history.
Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

HUM Stock News Headlines

Research Analysts Set Expectations for Humana Q1 Earnings
Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
See More Headlines

HUM Stock Analysis - Frequently Asked Questions

Humana's stock was trading at $253.71 on January 1st, 2025. Since then, HUM shares have decreased by 6.0% and is now trading at $238.5750.

Humana Inc. (NYSE:HUM) issued its quarterly earnings results on Wednesday, April, 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. The company's quarterly revenue was up 8.4% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Humana: Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and others.

Top institutional investors of Humana include Central Pacific Bank Trust Division and Kera Capital Partners Inc.. Insiders that own company stock include Bruce D Broussard, David A Jr/Ky Jones, Timothy S Huval, Joseph C Ventura, Susan M Diamond, Jorge S Mesquita and William Kevin Fleming.
View institutional ownership trends
.

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AU Optronics (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

Record date for 4/25 Dividend
3/28/2025
Ex-Dividend for 4/25 Dividend
3/28/2025
Dividend Payable
4/25/2025
Last Earnings
4/30/2025
Record date for 7/25 Dividend
6/27/2025
Ex-Dividend for 7/25 Dividend
6/27/2025
Today
7/05/2025
Dividend Payable
7/25/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:HUM
Employees
65,680
Year Founded
1961

Price Target and Rating

Average Stock Price Target
$280.76
High Stock Price Target
$326.00
Low Stock Price Target
$250.00
Potential Upside/Downside
+17.7%
Consensus Rating
Hold
Rating Score (0-4)
2.30
Research Coverage
23 Analysts

Profitability

Trailing P/E Ratio
16.87
Forward P/E Ratio
14.49
P/E Growth
1.81
Net Income
$1.21 billion
Pretax Margin
1.99%

Debt

Sales & Book Value

Annual Sales
$117.76 billion
Cash Flow
$23.76 per share
Price / Cash Flow
10.04
Book Value
$136.57 per share
Price / Book
1.75

Miscellaneous

Free Float
120,246,000
Market Cap
$28.79 billion
Optionable
Optionable
Beta
0.44

Social Links

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NYSE:HUM) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners